Completed PHASE1 INTERVENTIONAL 2-arm NCT01699308

Growth Hormone and Brain Functioning After Traumatic Brain Injury (GH)

Growth Hormone and Brain Functioning After Traumatic Brain Functioning

Sponsor: Joe Springer

Interventions Genotropin

Updated 7 times since 2017 Last updated: Sep 6, 2018 Started: Dec 1, 2009 Primary completion: Apr 1, 2014 Completion: Apr 1, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Traumatic Brain Injury and is currently completed. Joe Springer leads this study, which shows 7 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Oct 2018 — Jan 2021 [monthly]

Completed PHASE1

Status: Unknown Status → Completed · Phase: PHASE4 → PHASE1
Jun 2018 — Oct 2018 [monthly]

Unknown Status PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE4
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Joe Springer

Data source: University of Kentucky

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lexington, United States